Please login to the form below

Not currently logged in
Email:
Password:

Inovio Biomedical elects new Board members

Inovio Biomedical Corporation has announced the election of David J Williams and Keith H Wells to its Board

DNA vaccine design, development and delivery firm Inovio Biomedical Corporation has announced the election of David J Williams, former chairman and CEO of Sanofi Pasteur, and Keith H Wells, a senior member of the Biologics Consulting Group and former director of vaccine development for The Salk Institute, to its Board. 

Dr J Joseph Kim, president and CEO of Inovio, said: "These two business leaders each have multiple decades of experience leading and executing the development and commercialisation of cutting-edge vaccine technology and important new vaccines. Their expertise will be invaluable to Inovio as we advance a new generation of vaccines – DNA vaccines delivered using the potency-enhancing capabilities of electroporation – that are displaying superior results and potential to not only prevent but treat challenging infectious diseases and cancers."

26th October 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...
Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...

Infographics